YKL-40 as a biomarker in various inflammatory diseases: A review

Biochem Med (Zagreb). 2024 Feb 15;34(1):010502. doi: 10.11613/BM.2024.010502. Epub 2023 Dec 15.

Abstract

YKL-40 or Chitinase-3-Like Protein 1 (CHI3L1) is a highly conserved glycoprotein that binds heparin and chitin in a non-enzymatic manner. It is a member of the chitinase protein family 18, subfamily A, and unlike true chitinases, YKL-40 is a chitinase-like protein without enzymatic activity for chitin. Although its accurate function is yet unknown, the pattern of its expression in the normal and disease states suggests its possible engagement in apoptosis, inflammation and remodeling or degradation of the extracellular matrix. During an inflammatory response, YKL-40 is involved in a complicated interaction between host and bacteria, both promoting and attenuating immune response and potentially being served as an autoantigen in a vicious circle of autoimmunity. Based on its pathophysiology and mechanism of action, the aim of this review was to summarize research on the growing role of YKL-40 as a persuasive biomarker for inflammatory diseases' early diagnosis, prediction and follow-up (e.g., cardiovascular, gastrointestinal, endocrinological, immunological, musculoskeletal, neurological, respiratory, urinary, infectious) with detailed structural and functional background of YKL-40.

Keywords: Chitinase-3-Like Protein 1; YKL-40; biomarkers; chitinases; inflammation.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers* / blood
  • Biomarkers* / metabolism
  • Chitinase-3-Like Protein 1* / metabolism
  • Disease* / genetics
  • Early Diagnosis
  • Humans
  • Inflammation* / enzymology
  • Inflammation* / genetics
  • Research / trends

Substances

  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1
  • Biomarkers